×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PALI – palisade bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PALI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
09:00 am
pali
Palisade Bio Announces Participation in Two Upcoming Investor Conferences
Medium
Report
Palisade Bio Announces Participation in Two Upcoming Investor Conferences
2/25
08:00 am
pali
Palisade Bio (PALI) is now covered by Stifel Nicolaus. They set a "buy" rating and a $5.00 price target on the stock.
Medium
Report
Palisade Bio (PALI) is now covered by Stifel Nicolaus. They set a "buy" rating and a $5.00 price target on the stock.
2/23
08:40 am
pali
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
Low
Report
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
2/17
08:45 am
pali
Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
Low
Report
Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
2/9
09:13 am
pali
Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium [Yahoo! Finance]
Medium
Report
Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium [Yahoo! Finance]
2/9
09:00 am
pali
Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium
Medium
Report
Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium
2/7
02:07 am
pali
Palisade Bio (NASDAQ:PALI) was downgraded by analysts at Wall Street Zen
Medium
Report
Palisade Bio (NASDAQ:PALI) was downgraded by analysts at Wall Street Zen
2/5
08:45 am
pali
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Medium
Report
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/17
04:41 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
2/17
04:29 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
2/17
04:00 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: PERCEPTIVE ADVISORS LLC
2/17
12:09 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Squadron Capital Management LLC
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Squadron Capital Management LLC
2/13
08:10 pm
pali
Form 4 PALISADE BIO, INC. For: Feb 11 Filed by: Jones Mitchell Lawrence
Low
Report
Form 4 PALISADE BIO, INC. For: Feb 11 Filed by: Jones Mitchell Lawrence
2/13
08:08 pm
pali
Form 4 PALISADE BIO, INC. For: Feb 11 Filed by: Finley John David
Low
Report
Form 4 PALISADE BIO, INC. For: Feb 11 Filed by: Finley John David
2/13
08:51 am
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Deep Track Capital, LP
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Deep Track Capital, LP
2/11
05:35 pm
pali
Form 4 PALISADE BIO, INC. For: Feb 09 Filed by: Jones Mitchell Lawrence
Neutral
Report
Form 4 PALISADE BIO, INC. For: Feb 09 Filed by: Jones Mitchell Lawrence
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: